Skip to main content
Clinical Trials/NCT02655991
NCT02655991
Completed
Not Applicable

Homecoming Line: Telephone Support for Veterans

VA Palo Alto Health Care System3 sites in 1 country358 target enrollmentMarch 2008

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Stress Disorders, Post-Traumatic
Sponsor
VA Palo Alto Health Care System
Enrollment
358
Locations
3
Primary Endpoint
PTSD Checklist (PCL) Slope
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

This study will determine whether telephone support improves clinical outcomes of veterans who begin outpatient treatment for posttraumatic stress disorder. Participants will be randomly assigned to receive either usual care or usual care supplemented by biweekly monitoring and support by telephone during the first 3 months of treatment. Patients in both conditions will be compared on PTSD symptoms, engagement in treatment, violence and drinking at 4 months and 12 months after entering treatment.

Detailed Description

This multisite randomized controlled trial will test whether a 3-month period of providing telephone monitoring to PTSD patients as a supplement to usual specialty mental health care improves 12-month clinical outcomes (a reduction in PTSD symptoms, violence, and substance use). Secondarily, this study will determine whether telephone monitoring promotes better engagement in outpatient treatment (Number of mental health and psychotherapy visits during the 3-month intervention period). Demand for VA PTSD treatment is increasing as troops return from combat deployments in Afghanistan and Iraq. Telemedicine is likely to be an important component in developing more effective and efficient models of PTSD care that improves patient functioning and treatment utilization. It is hoped that using telephone case monitoring as an inexpensive adjunct to standard care may improve clinical outcomes and reduce hospitalization among veterans with PTSD.

Registry
clinicaltrials.gov
Start Date
March 2008
End Date
August 2014
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Sponsor
VA Palo Alto Health Care System
Responsible Party
Principal Investigator
Principal Investigator

Craig S. Rosen, Ph.D.

Deputy Director, National Center for PTSD

VA Palo Alto Health Care System

Eligibility Criteria

Inclusion Criteria

  • VA patients newly entering outpatient treatment mental health treatment for PTSD starting a new phase of outpatient PTSD treatment (e.g., transitioning from a psycho-education group to active psychotherapy) at one of the study sites.

Exclusion Criteria

  • Active duty personnel
  • Cognitive impairment which precludes giving informed consent
  • Initiating residential or inpatient treatment rather than outpatient treatment

Outcomes

Primary Outcomes

PTSD Checklist (PCL) Slope

Time Frame: 12 months

Slope of improvement on the PTSD Checklist, a self-report measure of PTSD symptoms.

Secondary Outcomes

  • Quality of Life slope(12 months)
  • Other mental health visits -- follow-up period(months 4-12)
  • Other mental health visits - intervention period(3 months)
  • PTSD psychotherapy visits - intervention period(3 months)
  • Depression slope(12 months)
  • Aggression slope(12 months)
  • Prazosin refills (medication possession ratio)(12 months)
  • Alcohol problems slope(12 months)
  • Drug problems slope(12 months)
  • PTSD psychotherapy visits -- follow-up period(months 4-12)
  • Selective serotonin reuptake inhibitor refills (medication possession ratio)(12 months)

Study Sites (3)

Loading locations...

Similar Trials